Population-based study of grade progression in patients who harboured Gleason 3 + 3

Prostate Cancer, Version 3.2012 Featured Updates to the NCCN Guidelines

(2017) James L. Mohler et al.   Journal of the National Comprehensive Cancer Network

Feasibility for active surveillance in biopsy Gleason 3 + 4 prostate cancer: an Australian radical prostatectomy cohort

(2016) Lih-Ming Wong et al.   BJU INTERNATIONAL

Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement

(2016) Ronald C. Chen et al.   JOURNAL OF CLINICAL ONCOLOGY

An Increase in Gleason 6 Tumor Volume While on Active Surveillance Portends a Greater Risk of Grade Reclassification with Further Followup

(2016) Maria Komisarenko et al.   JOURNAL OF UROLOGY

Quality of care achievements of the Prostate Cancer Outcomes Registry–Victoria

(2016) Fanny Sampurno et al.   MEDICAL JOURNAL OF AUSTRALIA

The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry

(2015) Mahesha Weerakoon et al.   BJU INTERNATIONAL

Gleason Upgrading with Time in a Large Prostate Cancer Active Surveillance Cohort

(2015) Suneil Jain et al.   JOURNAL OF UROLOGY

Review by urological pathologists improves the accuracy of Gleason grading by general pathologists

(2015) Yasushi Nakai et al.   BMC Urology

The role of transperineal template prostate biopsies in prostate cancer diagnosis in biopsy naïve men with PSA less than 20 ng ml−1

(2014) S Nafie et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

The Prostate Cancer Registry: monitoring patterns and quality of care for men diagnosed with prostate cancer

(2012) Sue M. Evans et al.   BJU INTERNATIONAL

Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study

(2012) Meelan Bul et al.   EUROPEAN UROLOGY

The role of a standardized 36 core template-assisted transperineal prostate biopsy technique in patients with previously negative transrectal ultrasonography-guided prostate biopsies

(2011) Raj P. Pal et al.   BJU INTERNATIONAL

Changes in Cancer Volume in Serial Biopsies of Men on Active Surveillance for Early Stage Prostate Cancer

(2011) Sima P. Porten et al.   JOURNAL OF UROLOGY

Short-term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study

(2009) Roderick C.N. van den Bergh et al.   BJU INTERNATIONAL

Pretreatment Prostate-Specific Antigen (PSA) Velocity and Doubling Time Are Associated With Outcome but Neither Improves Prediction of Outcome Beyond Pretreatment PSA Alone in Patients Treated With Radical Prostatectomy

(2009) Matthew Frank O'Brien et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: Results from a single institution series

(2009) Derya Tilki et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study

(2008) Rune Kvåle et al.   BJU INTERNATIONAL

Change in Prostate Cancer Grade Over Time in Men Followed Expectantly for Stage T1c Disease

(2008) Todd B. Sheridan et al.   JOURNAL OF UROLOGY

PSA Velocity Is Associated With Gleason Score in Radical Prostatectomy Specimen: Marker for Prostate Cancer Aggressiveness

(2008) Stacy Loeb et al.   UROLOGY

Diagnosis and treatment of prostate cancer: summary of NICE guidance

(2008) John Graham et al.   BMJ-British Medical Journal